l General Information |
Product Name | Empagliflozin |
General description | Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor. |
Synonym | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6 (hydroxymethyl)oxane-3,4,5-triol; BI 10773 |
Purity | ≥99.0%(HPLC) | CAS Number | 864070-44-0 |
Formula | C23H27ClO7 | Molecular Weight | 450.91 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor. |
Application | Hypoglycemic Agents |
l Packaging & Storage |
Packaging | 10mg; 25mg; 100mg; 250mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
